Innate immunity as a target for acute cardioprotection

Area of Science:

• Cardiovascular Research
• Immunology
• Pathophysiology

Background:

• Acute coronary artery obstruction leads to myocardial ischemia and ST-segment elevation myocardial infarction (STEMI).
• The inflammatory response to injury can paradoxically worsen myocardial damage.
• Infarct size correlates with the risk of developing heart failure.

Purpose of the Study:

• To review the role of the innate immune system in acute ischemia-reperfusion (IR) injury.
• To examine the contribution of innate immunity to cell death and myocardial infarction.
• To explore potential therapeutic targets within the innate immune system for cardioprotection.

Main Methods:

• Review of current literature on innate immunity and myocardial IR injury.
• Discussion of danger-associated molecular patterns (DAMPs) and pattern recognition receptors (PRRs).
• Analysis of inflammasome activation, including NLRP3, caspase 1, and pyroptosis.

Main Results:

• Dying cardiac cells release DAMPs, activating PRRs like Toll-like receptors and NOD-like receptors (NLRs).
• NLRP3 inflammasome activation, caspase 1, and pyroptosis contribute to myocardial injury, especially with comorbidities.
• Innate immunity pathways are implicated in both myocardial injury and cardioprotection.

Conclusions:

• Targeting innate immunity presents a potential therapeutic avenue for STEMI patients.
• Careful consideration of agent dosing and timing is crucial due to the dual role of innate immunity.
• Further research is needed to optimize therapeutic strategies for innate immunity modulation in cardioprotection.